G protein-coupled receptor heteromers as new targets for drug development

Progress in Molecular Biology and Translational Science

Volumn 91, Issue C, 2010, Pages 41-52

  Ferr, Sergi ^a   Navarro, Gemma ^b   Casad, Vicent ^b   Corts, Antoni ^b   Mallol, Josefa ^b   Canela, Enric I ^b   Llus, Carme ^b   Franco, Rafael ^b,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LUMINESCENCE; METABOLISM; PROTEIN QUATERNARY STRUCTURE; REVIEW;

ANIMALS; DRUG DISCOVERY; ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LUMINESCENT MEASUREMENTS; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 77957278232     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)91002-8     Document Type: Chapter

References (55)

1. M.R. Whorton, M.P. Bokoch, S.G. Rasmussen, B. Huang, R.N. Zare, and B. Kobilka A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein Proc Natl Acad Sci USA 104 2007 7682 7687 (Pubitemid 47185966)
2. M.R. Whorton, B. Jastrzebska, P.S. Park, D. Fotiadis, A. Engel, and K. Palczewski Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer J Biol Chem 283 2008 4387 4394
3. A.J. Kuszak, S. Pitchiaya, J.P. Anand, H.I. Mosberg, N.G. Walter, and R.K. Sunahara Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2 J Biol Chem 284 2009 6732 26741
4. O.P. Ernst, V. Gramse, M. Kolbe, K.P. Hofmann, and M. Heck Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit Proc Natl Acad Sci USA 104 2007 10859 10864 (Pubitemid 47175191)
5. S. Ferr, R. Baler, M. Bouvier, M.G. Caron, L.A. Devi, and T. Durroux Building a new conceptual framework for receptor heteromers Nat Chem Biol 5 2009 131 134
6. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol Rev 51 1999 7 61 (Pubitemid 29113865)
7. C. Gotti, M. Zoli, and F. Clementi Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends Pharmacol Sci 27 2006 482 491 (Pubitemid 44251225)
8. M.S. Airaksinen, and M. Saarma The GDNF family: signalling, biological functions and therapeutic value Nat Rev Neurosci 3 2002 383 394 (Pubitemid 135706635)
9. J.P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, and J.A. Javitch International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers Pharmacol Rev 59 2007 5 13 (Pubitemid 46335687)
10. Y. Han, I.S. Moreira, E. Urizar, H. Weinstein, and J.A. Javitch Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation Nat Chem Biol 5 2009 688 695
11. S. Ferr, F. Ciruela, A.S. Woods, C. Lluis, and R. Franco Functional relevance of neurotransmitter receptor heteromers in the central nervous system Trends Neurosci 30 2007 440 446 (Pubitemid 47381459)
12. G. Milligan, and N.J. Smith Allosteric modulation of heterodimeric G-protein-coupled receptors Trends Pharmacol Sci 28 2007 615 620 (Pubitemid 350166577)
13. V. Casad, A. Corts, F. Ciruela, J. Mallol, S. Ferr, and C. Lluis Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index Pharmacol Ther 116 2007 343 354 (Pubitemid 350123634)
14. V. Casad, A. Corts, J. Mallol, K. Prez-Capote, S. Ferr, and C. Lluis GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacol Ther 124 2009 248 257
15. M. Waldhoer, S.E. Bartlett, and J.L. Whistler Opioid receptors Annu Rev Biochem 73 2004 953 990 (Pubitemid 39050391)
16. S.R. George, T. Fan, Z. Xie, R. Tse, V. Tam, and G. Varghese Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties J Biol Chem 275 2000 26128 26135
17. I. Gomes, A. Gupta, J. Filipovska, H.H. Szeto, J.E. Pintar, and L.A. Devi A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia Proc Natl Acad Sci USA 101 2004 5135 5139 (Pubitemid 38469214)
18. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700
19. R.M. van Rijn, and J.L. Whistler The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake Biol Psychiatry 66 2009 777 784
20. K. Herrick-Davis, E. Grinde, T.J. Harrigan, and J.E. Mazurkiewicz Inhibition of serotonin 5-hydroxytryptamine 2C receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein J Biol Chem 280 2005 40144 40151 (Pubitemid 41779150)
21. R. Leurs, R.A. Bakker, H. Timmerman, and I.J. de Esch The histamine H3 receptor: from gene cloning to H3 receptor drugs Nat Rev Drug Discov 4 2005 107 120
22. C. Fiorentini, C. Busi, E. Gorruso, C. Gotti, P. Spano, and C. Missale Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization Mol Pharmacol 74 2008 59 69 (Pubitemid 351872159)
23. C. Ferrada, E. Moreno, V. Casad, G. Bongers, A. Corts, and J. Mallol Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors Br J Pharmacol 157 2009 64 75
24. A.J. Rashid, C.H. So, M.M. Kong, T. Furtak, M. El-Ghundi, and R. Cheng D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum Proc Natl Acad Sci USA 9 2007 654 659 (Pubitemid 46123080)
25. C.H. So, V. Verma, M. Alijaniaram, R. Cheng, A.J. Rashid, and B.F. O'Dowd Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers Mol Pharmacol 75 2009 843 854
26. K.P. Minneman Heterodimerization and surface localization of G protein coupled receptors Biochem Pharmacol 73 2007 1043 1050
27. S. Wilson, G. Wilkinson, and G. Milligan The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities J Biol Chem 280 2005 28663 28674 (Pubitemid 41105767)
28. R.L. Contento, B. Molon, C. Boularan, T. Pozzan, S. Manes, and S. Marullo CXCR4-CCR5: a couple modulating T cell functions Proc Natl Acad Sci USA 195 2008 10101 10106
29. G. Milligan Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors Eur J Pharm Sci 21 2004 397 405 (Pubitemid 38283913)
30. K.D. Pfleger, and K.A. Eidne Monitoring the formation of the dynamic G-protein-coupled receptor-protein complexes in living cells Biochem J 385 2005 625 637
31. S. Marullo, and M. Bouvier Resonance energy transfer approaches in molecular pharmacology and beyond Trends Pharmacol Sci 28 2007 362 365 (Pubitemid 47087970)
32. M.A. Ayoub, and K.D.G. Pfleger Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization Curr Opin Pharmacol 10 2010 44 52
33. M.A. Ayoub, A. Levoye, P. Delagrange, and R. Jockers Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers Mol Pharmacol 66 2004 312 321 (Pubitemid 38989488)
34. J.P. Vilardaga, V.O. Nikolaev, K. Lorenz, S. Ferrandon, Z. Zhuang, and M.J. Lohse Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling Nat Chem Biol 4 2008 126 131
35. P. Carriba, G. Navarro, F. Ciruela, S. Ferr, V. Casad, and L.F. Agnati Detection of heteromerization of more than two proteins by sequential BRET-FRET Nat Methods 5 2008 727 733
36. N. Cabello, J. Ganda, D.C. Bertarelli, M. Watanabe, C. Llus, and R. Franco Metabotropic glutamate type 5, dopamine D2 and adenosine A2A receptors form higher-order oligomers in living cells J Neurochem 109 2009 1497 1507
37. G. Navarro, P. Carriba, J. Ganda, F. Ciruela, V. Casad, and A. Corts Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer ScientificWorldJournal 8 2008 1088 1097
38. J. Ganda, C. Llus, S. Ferr, R. Franco, and F. Ciruela Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization Bioessays 30 2008 82 89
39. D. Maurel, L. Comps-Agrar, C. Brock, M.L. Rives, E. Bourrier, and M.A. Ayoub Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization Nat Methods 5 2008 561 567 (Pubitemid 351761765)
40. S. Dorsch, K.-N. Klotz, S. Engelhardt, M.J. Lohse, and M. Bunemann Analysis of receptor oligomerization by FRAP microscopy Nat Methods 6 2009 225 230
41. A. Soriano, R. Ventura, A. Molero, R. Hoen, V. Casad, and A. Corts Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers J Med Chem 52 2009 5590 5602
42. L.M. Simpson, B. Taddese, I.D. Wall, and C.A. Reynolds Bioinformatics and molecular modeling approaches to GPCR oligomerization Curr Opin Pharmacol 10 2010 30 37
43. C.E. Mller, and S. Ferr Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders Recent Pat CNS Drug Discov 2 2007 1 21
44. S. Ferr, C. Quiroz, A.S. Woods, R. Cunha, P. Popoli, and F. Ciruela An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors Curr Pharm Des 14 2008 1468 1474 (Pubitemid 351997812)
45. 2 receptors Anal Chem 76 2004 5354 5363 (Pubitemid 39249416)
46. A.S. Woods, and S. Ferr The amazing stability of the arginine-phosphate electrostatic interaction J Proteome Res 4 2005 1397 1402
47. W. Guo, E. Urizar, M. Kralikova, J.C. Mobarec, L. Shi, and M. Filizola Dopamine D2 receptors form higher order oligomers at physiological expression levels EMBO J 27 2008 2293 2304
48. J. Gonzlez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, and J.F. Lpez-Gimnez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97 (Pubitemid 351355090)
49. K. Azdad, D. Gall, A.S. Woods, C. Ledent, S. Ferr, and S.N. Schiffmann Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization Neuropsychopharmacology 34 2009 972 986
50. D.J. Daniels, N.R. Lenard, C.L. Etienne, P.Y. Law, S.C. Roerig, and P.S. Portoghese Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series Proc Natl Acad Sci USA 102 2005 19208 19213
51. G. Scherrer, N. Imamachi, Y.Q. Cao, C. Contet, F. Mennicken, and D. O'Donnell Dissociation of the opioid receptor mechanisms that control mechanical and heat pain Cell 137 2009 1148 1159
52. G. Scherrer, P. Tryoen-Tth, D. Filliol, A. Matifas, D. Laustriat, and Y.Q. Cao Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo Proc Natl Acad Sci USA 103 2006 9691 9696 (Pubitemid 43955886)
53. H.B. Wang, J.S. Guan, L. Bao, and X. Zhang Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells Neurochem Res 33 2008 2028 2034
54. F.M. Dcaillot, R. Rozenfeld, A. Gupta, and L.A. Devi Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4 Proc Natl Acad Sci USA 105 2008 16045 16050
55. D. Marcellino, S. Ferr, V. Casad, A. Corts, B. Le Foll, and C. Mazzola Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum J Biol Chem 283 2008 26016 26025